| Colorado Mental Health Institute At Pueblo-psych | |
| 1600 W 24th St, Pueblo, Colorado 81003 | |
| (719) 546-4000 | |
| Not Available |
| Name | Colorado Mental Health Institute At Pueblo-psych |
|---|---|
| Type | Psychiatric Hospital |
| Location | 1600 W 24th St, Pueblo, Colorado |
| Ownership | Government - State |
| Emergency Services | Yes |
| Medicare ID (CCN) | 064001 |
| NPI Number | 1144352550 |
| Organization Name | STATE OF COLORADO |
| Doing Business As | PSYCHIATRIC HOSPITAL |
| Address | 1600 W 24th St, Pueblo, CO 81003 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 719-546-4000 |
News Archive
Medasense Biometrics Ltd. announced today that it has received CE mark approval for its novel Pain Monitoring Device, PMD200™. This new technology is now available to help physicians objectively assess a patient's pain in critical care situations, where patients are unable to communicate. This allows physicians to ensure pain is properly managed.
When Linda Mercer underwent a radical hysterectomy to treat her cancer, she found herself and her husband struggling to regain a satisfying sex life.
Inhibikase Therapeutics, a specialty pharmaceutical company based in Atlanta, Georgia, will discuss simultaneous antiviral and antibacterial activity from small molecule agents at the 2009 BIOCOM Investor Conference. Employing a host-factor targeted approach, Inhibikase will illustrate the utility of IkT-001 and IkT-041 to treat multiple infectious diseases in humans.
Two scientists from the John Innes Centre have been elected as Fellows of the Royal Society, the premier scientific accolade in the UK. Their breakthroughs in fundamental research have pioneered advances in antibiotic discovery and in crop improvement from which we all benefit.
In an analysis of three different types of radiation therapy used to treat localized prostate cancer, compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses of gastrointestinal adverse effects, hip fractures, and receipt of additional cancer treatments but more erectile dysfunction, while proton therapy was associated with more gastrointestinal adverse effects than IMRT.
› Verified 5 days ago
| NPI Number | 1326170739 |
| Organization Name | STATE OF COLORADO |
| Address | 1600 W 24th St, Pueblo, CO 81003 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 719-546-4000 |
News Archive
Medasense Biometrics Ltd. announced today that it has received CE mark approval for its novel Pain Monitoring Device, PMD200™. This new technology is now available to help physicians objectively assess a patient's pain in critical care situations, where patients are unable to communicate. This allows physicians to ensure pain is properly managed.
When Linda Mercer underwent a radical hysterectomy to treat her cancer, she found herself and her husband struggling to regain a satisfying sex life.
Inhibikase Therapeutics, a specialty pharmaceutical company based in Atlanta, Georgia, will discuss simultaneous antiviral and antibacterial activity from small molecule agents at the 2009 BIOCOM Investor Conference. Employing a host-factor targeted approach, Inhibikase will illustrate the utility of IkT-001 and IkT-041 to treat multiple infectious diseases in humans.
Two scientists from the John Innes Centre have been elected as Fellows of the Royal Society, the premier scientific accolade in the UK. Their breakthroughs in fundamental research have pioneered advances in antibiotic discovery and in crop improvement from which we all benefit.
In an analysis of three different types of radiation therapy used to treat localized prostate cancer, compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses of gastrointestinal adverse effects, hip fractures, and receipt of additional cancer treatments but more erectile dysfunction, while proton therapy was associated with more gastrointestinal adverse effects than IMRT.
› Verified 5 days ago
| NPI Number | 1457483851 |
| Organization Name | COLORADO MENTAL HEALTH INSTITUTE PUEBLO |
| Address | 1600 W 24th St, Pueblo, CO 81003 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 719-546-4000 |
News Archive
Medasense Biometrics Ltd. announced today that it has received CE mark approval for its novel Pain Monitoring Device, PMD200™. This new technology is now available to help physicians objectively assess a patient's pain in critical care situations, where patients are unable to communicate. This allows physicians to ensure pain is properly managed.
When Linda Mercer underwent a radical hysterectomy to treat her cancer, she found herself and her husband struggling to regain a satisfying sex life.
Inhibikase Therapeutics, a specialty pharmaceutical company based in Atlanta, Georgia, will discuss simultaneous antiviral and antibacterial activity from small molecule agents at the 2009 BIOCOM Investor Conference. Employing a host-factor targeted approach, Inhibikase will illustrate the utility of IkT-001 and IkT-041 to treat multiple infectious diseases in humans.
Two scientists from the John Innes Centre have been elected as Fellows of the Royal Society, the premier scientific accolade in the UK. Their breakthroughs in fundamental research have pioneered advances in antibiotic discovery and in crop improvement from which we all benefit.
In an analysis of three different types of radiation therapy used to treat localized prostate cancer, compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses of gastrointestinal adverse effects, hip fractures, and receipt of additional cancer treatments but more erectile dysfunction, while proton therapy was associated with more gastrointestinal adverse effects than IMRT.
› Verified 5 days ago
News Archive
Medasense Biometrics Ltd. announced today that it has received CE mark approval for its novel Pain Monitoring Device, PMD200™. This new technology is now available to help physicians objectively assess a patient's pain in critical care situations, where patients are unable to communicate. This allows physicians to ensure pain is properly managed.
When Linda Mercer underwent a radical hysterectomy to treat her cancer, she found herself and her husband struggling to regain a satisfying sex life.
Inhibikase Therapeutics, a specialty pharmaceutical company based in Atlanta, Georgia, will discuss simultaneous antiviral and antibacterial activity from small molecule agents at the 2009 BIOCOM Investor Conference. Employing a host-factor targeted approach, Inhibikase will illustrate the utility of IkT-001 and IkT-041 to treat multiple infectious diseases in humans.
Two scientists from the John Innes Centre have been elected as Fellows of the Royal Society, the premier scientific accolade in the UK. Their breakthroughs in fundamental research have pioneered advances in antibiotic discovery and in crop improvement from which we all benefit.
In an analysis of three different types of radiation therapy used to treat localized prostate cancer, compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses of gastrointestinal adverse effects, hip fractures, and receipt of additional cancer treatments but more erectile dysfunction, while proton therapy was associated with more gastrointestinal adverse effects than IMRT.
› Verified 5 days ago
St Mary Corwin Med Ctr, Centura Health Acute Care Hospital Location: 1008 Minnequa Ave, Pueblo, Colorado 81004 Phone: (719) 557-4000 | |
Parkview Medical Center, Inc Acute Care Hospital Location: 400 W 16th St, Pueblo, Colorado 81003 Phone: (719) 584-4000 | |
Colorado Mental Health Institute At Pueblo-psych Psychiatric Hospital Location: 1600 W 24th St, Pueblo, Colorado 81003 Phone: (719) 546-4000 |